对乙型肝炎和乙型肝炎的治疗方法和管道
James Lee1, Nishali Shah1, Rahul Kukreja1
1Department of Internal Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
Clinics in liver disease
|October 18, 2025
概括
本概述涵盖了当前和新兴的乙型肝炎病毒 (HBV) 治疗方法. 它详细介绍了抗病毒药物,免疫调节剂和基因疗法,以控制HBV感染并预防肝病.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 药理学 药理学是指药理学的学科.
背景情况:
- 乙型肝炎病毒 (HBV) 感染对全球健康构成重大挑战.
- 有效的管理旨在抑制病毒复制并阻止肝病的进展.
- 目前的治疗方法专注于控制病毒,但往往无法治愈.
研究的目的:
- 为B型肝炎病毒感染提供当前和新兴治疗策略的全面概述.
- 为医疗保健专业人员提供有关不断变化的治疗环境的信息.
- 突出关键药物类别和正在调查中的新药剂.
主要方法:
- 对当前临床实践和B型肝炎治疗药物的正在进行的研究进行文献综述.
- 对已知抗病毒药物的分析,包括核胺类同类物和基化干扰素.
- 探索新的治疗途径,如囊/核心抑制剂,免疫调节剂,基因编辑和疫苗.
主要成果:
- 目前的治疗方法包括核胺类型 (例如,tenofovir, entecavir) 和用于病毒抑制的基化干扰素.
- 新兴的治疗方法在向HBV生命周期的不同方面显示出前途.
- 目前正在调查的新型药物包括体/核抑制剂,免疫调节剂,基因编辑技术和治疗疫苗.
结论:
- 随着新的治疗方法的发展,B型肝炎病毒感染的管理正在不断发展.
- 现有和新型疗法的组合可能为患者提供更好的结果.
- 对创新的治疗方法的持续研究对于实现B型肝炎的功能治愈至关重要.
更多相关视频
相关概念视频
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
01:17Hepatic Drug Excretion: Enterohepatic Cycling
2.6K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
2.6K
01:10Retrovirus Life Cycles
49.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.3K
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
210
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
210
01:29Microorganisms in Medicine and Therapeutics
936
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
936
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
211
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
211